systhiperСистемные гипертензииSystemic Hypertension2075-082X2542-2189LLC «ИнтерМедсервис»systhiper-181Research ArticleСТАТЬИARTICLESИсследование HYVET - важнейшее
клиническое исследование 2008 г.
в рейтинге Общества клинических
исследований и Американской
ассоциации сердцаHYVET: landmark trial voted 2008 Trial
of the Year by the ImpACT/Society for Clinical Trials and the American Heart AssociationСтатьяРедакционнаяArticleEditorialnoemail@neicon.ru200923122022624445Copyright © Статья Р., 20222022Статья Р.Article E.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.syst-hypertension.ru/jour/article/view/181артериальная гипертония у пожилыхиндапамидпериндоприлArterial hypertension in the elderlyindapamidperindoprilReferencesBeckett NS, Peters R, Fletcher AE et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008; 358: 1887-98.Beckett NS, Peters R, Fletcher AE et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008; 358: 1887-98.United Nations. World population ageing 1950-2050. IV. Demographic profile of the older population. Available from http://www.un.org/esa/population/publications/worldageing19502050/pdf/90chapteriv.pdf.United Nations. World population ageing 1950-2050. IV. Demographic profile of the older population. Available from http://www.un.org/esa/population/publications/worldageing19502050/pdf/90chapteriv.pdf.Leonetti G, Emeriau J-P, Knauf H et al. Evaluation of long-term efficacy and acceptability of indapamide SR in elderly hypertensive patients. Curr Med Res Opin 2005; 21: 37-46.Leonetti G, Emeriau J-P, Knauf H et al. Evaluation of long-term efficacy and acceptability of indapamide SR in elderly hypertensive patients. Curr Med Res Opin 2005; 21: 37-46.Peters R, Beckett N, Forette F et al. Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial. Lancet 2008; 7: 683-9.Peters R, Beckett N, Forette F et al. Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial. Lancet 2008; 7: 683-9.American Heart Association. News release. Top research advances include studies that influence medical care, apply science to «real world» communities. January 21, 2009. Available from http://americanheart.mediaroom.com/index.php?s=43&item=648.American Heart Association. News release. Top research advances include studies that influence medical care, apply science to «real world» communities. January 21, 2009. Available from http://americanheart.mediaroom.com/index.php?s=43&item=648.Medscape Cardiology. This Year's Awards for the Most Important Trials Go to... HYVET and ACCOMPLISH. March 2, 2009. Available from http://cme.medscape.com/viewarticle/588818.Medscape Cardiology. This Year's Awards for the Most Important Trials Go to... HYVET and ACCOMPLISH. March 2, 2009. Available from http://cme.medscape.com/viewarticle/588818.Faculty of 1000 Medicine. All time Top 10 by F1000 factor. All of Medicine. March 30, 2009. Available from http://www.f1000medicine.com/top10/ classics/.Faculty of 1000 Medicine. All time Top 10 by F1000 factor. All of Medicine. March 30, 2009. Available from http://www.f1000medicine.com/top10/ classics/.Weidmann P. Metabolic profile of indapamide sustained-release in patients with hypertension. Drugs Safety 2001; 24: 1155-65.Weidmann P. Metabolic profile of indapamide sustained-release in patients with hypertension. Drugs Safety 2001; 24: 1155-65.
The authors declare that there are no conflicts of interest present.